Patents
Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
04/2007
04/05/2007US20070078269 Sulfonium or iodonium salt of aryl(methyl) sulfoacetate in which the alpha carbon is fluoro- or perfluoroalkyl-substituted: triphenylsulfonium (1-(5-hydroxynaphthyl)oxyethoxycarbonyl) difluoromethanesulfonate; acid labile resin; 2-Ethyl-2-adamantyl methacrylate copolymer; improve line edge roughness
04/04/2007EP1769794A1 Medicament for preventing and/or treating sleep disorder
04/04/2007CN1942462A Chiral heptyne derivatives for the preparation of epothilones and processes for their preparation
04/04/2007CN1308316C Alpha-phenyl-beta-ketosulfone
04/03/2007CA2102946C Insect lures
03/2007
03/29/2007CA2622912A1 Cytotoxin compounds and methods of isolation
03/28/2007EP1767535A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
03/28/2007EP1765803A1 Quaternary salt ccr2 antagonists
03/28/2007EP1765073A2 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
03/28/2007CN1938014A Solid preparation containing dibenz[b,e]oxepine derivative
03/28/2007CN1307171C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
03/27/2007US7195747 Process for mixing and reacting two or more fluids
03/22/2007US20070065920 For treatment of microbial conditions (including malaria), proliferative disorders, inappropiate vascularisation, inhibition of angiogenesis;
03/21/2007CN1931827A 2- and 2,5-substituted phenylketo-enols
03/21/2007CN1305866C Method of extracting phenolic components from chinese medicine red sage root and its freeze dried powder injection agent
03/15/2007WO2005117588A3 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
03/14/2007EP1040103B1 Anilide derivative, production and use thereof
03/14/2007CN1927858A Novel phenolic acid compounds of tanshin polyphenolic acid N and application thereof
03/13/2007US7189757 Sleep disorders; side effect reduction
03/13/2007CA2286610C Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
03/07/2007EP1760067A2 Compounds with protected hydroxy groups
03/07/2007EP1760054A2 Process for producing cyclic compound
03/07/2007EP1759696A1 Antineoplastic cocoa extracts, methods for making, using
03/07/2007EP1758876A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids
02/2007
02/28/2007EP1757285A1 Preventive and/or therapeutic agent for chronic sinusitis
02/27/2007US7183420 Reacting hydrogen peroxide with 1-hydroperoxy-oxabicyclo(4.10.0)hexadecane in presence of copper catalyst
02/22/2007WO2007022089A2 Methods to identify therapeutic agents useful for treating and preventing atherosclerosis by counteracting the effect of cholesterol ozonation products
02/22/2007CA2618990A1 Methods to identify therapeutic agents useful for treating and preventing atherosclerosis by counteracting the effect of cholesterol ozonation products
02/15/2007US20070037990 Method of producing an organic compound comprising at least one oxygenated functional group
02/15/2007US20070037852 Migrastatin analogs and uses thereof
02/15/2007US20070037464 Isolation, formulation, and shaping of macrocyclic oligoesters
02/14/2007EP1126836B1 Benzamide potassium channel inhibitors
02/14/2007EP0946478B1 Process for the solid phase synthesis of aldehydes, ketones and hydroxamic acid compounds
02/14/2007CN1914198A Method of stabilizing macrolide compound
02/14/2007CN1911930A Chemokine receptor anagonists, methods and use therefor
02/13/2007US7176235 10,11-Dehydroepothilones; anticancer, antiproliferative and antiarthritic agents
02/13/2007US7176234 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
02/06/2007US7173137 Epothilone analogs
01/2007
01/31/2007EP1747211A1 Process for preparing unsaturated lactones
01/30/2007CA2286723C Tricyclic compounds
01/25/2007WO2007010383A1 Novel heterocyclidene acetamide derivative
01/24/2007CN1296366C Dibenzocyclooctane carboxylic ether compounds with herbicidal activity
01/23/2007US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
01/18/2007WO2006120010A3 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
01/17/2007EP1742707A2 Treatment of cns disorders using cns target modulators
01/17/2007EP1401575B1 Hydroxylation of beta-dicarbonyls with zirconium catalysts
01/17/2007CN1896070A 2- and 2,5-substituted phenylketo-enols
01/17/2007CN1295225C Bibenzyl compound plagiochin E and its extraction separation method and application
01/16/2007CA2257234C Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
01/16/2007CA2218981C Radicicol derivatives
01/10/2007EP1741715A1 Epothilone derivatives and their synthesis and use
01/10/2007EP1741706A1 11-methyl-13-tridecanolide, 12-methyl-14-tetradeca- nolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for the production of compounds including the same
01/10/2007EP1740523A1 New 1-methoxy-2-phenyl ethenes for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
01/09/2007US7160875 Malonamide derivatives
01/04/2007US20070004674 Remedy for diseases associated with immunoglobulin gene translocation
01/03/2007CN1293069C Method for producing novel spinosyn derivatives
12/2006
12/27/2006EP1373245B1 Intermediates for producing spinosyns
12/27/2006CN1886129A Use of pentadienoic acid derivates for treatment of hyperuricemia
12/21/2006US20060287371 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents
12/20/2006EP1551822B1 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them
12/20/2006CN1882528A Organic compounds
12/19/2006US7151116 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells
12/14/2006US20060281930 Esterification of acrylic or methacrylic acid with glycidol and an orthoester; halogen-free
12/13/2006EP1730140A1 Opioid receptor antagonists
12/13/2006CN1878547A Synthesis of oligomeric epicatechin and catechin-derived procyanidins
12/07/2006WO2006129781A1 Process for production of dibenzoxepin derivative
12/06/2006CN1875030A Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases
12/06/2006CN1875005A Malonamide derivatives blocking the activtiy of gamma-secretase
12/06/2006CN1872849A Method for synthesizing ú¿Sú®ú¿Êöú®- gamma - lactone
11/2006
11/30/2006WO2006034478A3 Isomigrastatin analogs in the treatment of cancer
11/30/2006US20060270862 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
11/29/2006EP0789568B1 Antineoplastic cocoa extracts, methods for making, using
11/23/2006WO2006122776A1 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
11/23/2006DE102005022020A1 New dibenzocycloheptane compounds are tumor necrosis factor-alpha inhibitors useful to treat e.g. cancer, rheumatic arthritis, gout, septic shock, osteoporosis, naturopathic pain, HIV-propagation and periodontal diseases
11/22/2006CN1865257A Cyclopropanated macrocyclic ketones and lactones
11/22/2006CN1865219A 2- and 2,5-substituted phenylketo-enols
11/16/2006WO2006120010A2 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
11/16/2006CA2608889A1 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
11/15/2006CN1861605A Fleshy glossy ganoderma lactone A, preparation process and use thereof
11/15/2006CN1861593A Large ring lactone compound containing meta-phenol ring and its application
11/08/2006EP1719775A1 Camptothecins with a modified lactone ring
11/08/2006EP1718631A2 Cytotoxin compound and method of isolation
11/07/2006US7132215 Ester compounds, polymers, resist compositions and patterning process
11/02/2006WO2006116165A1 Chromane and chromene derivatives and uses thereof
11/02/2006US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006EP1716153A2 Methods, compositions, and apparatuses for forming macrocyclic compounds
11/02/2006CA2605587A1 Chromane and chromene derivatives and uses thereof
10/2006
10/31/2006US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives
10/26/2006WO2006111491A1 Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives
10/26/2006WO2006036941A3 Specific kinase inhibitors
10/26/2006US20060241171 Novel physiologically active substances
10/26/2006CA2604257A1 Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives
10/25/2006EP1089998B1 Epothilone derivatives and their synthesis and use
10/24/2006US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers
10/24/2006CA2274183C Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
10/19/2006WO2005103041A3 Treatment of cns disorders using cns target modulators
10/18/2006EP1712538A1 Cyclopropanated macrocyclic ketones and lactones
10/18/2006EP1711470A1 Malonamide derivatives blocking the activtiy of gamma-secretase
10/18/2006CN1849312A Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics
10/18/2006CN1280271C Arylphenyl-substituted cyclic keto-enols
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 36